Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm characterized by the Philadelphia chromosome which is the source of a Bcr-Abl1 hybrid protein with constitutive tyrosine-kinase activity (1). This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.